

Point-of-Care Infectious Disease Diagnostics &
Testing Market
Point-of-Care Infectious Disease Diagnostics & Testing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031


Request Sample Report


Point-of-Care Infectious Disease Diagnostics & Testing
Market Size and Growth
The Point-of-Care Infectious Disease Diagnostics & Testing market is experiencing significant growth, driven by increasing demand for rapid, accurate diagnostics. The market is projected to reach approximately $5 billion by 2025, fueled by technological advancements and a focus on decentralized healthcare. Key trends include rising prevalence of infectious diseases and enhanced portability of testing devices. Request Sample Report

Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ Thermo Fisher Scientific Inc
◍ Roche
◍ Siemens Healthineers
◍ BD & Company
◍ Chembio Diagnostics Inc.
◍ Trinity Biotech
◍ Cardinal Health
◍ Quest Diagnostics Inc.
◍ Bio-Rad Labs Inc.
◍ bioMérieux SA
◍ Sight Diagnostics Ltd.
◍ Gene POC
◍ Trivitron Healthcare
◍ OJ-Bio Ltd.
◍ Ortho-Clinical Diagnostics
The Point-of-Care Infectious Disease Diagnostics & Testing Market features companies like Abbott and Roche, which develop rapid testing solutions. Thermo Fisher and BD enhance accuracy and efficiency, while bioMérieux and Quest Diagnostics expand accessibility. Collective innovations and diverse product portfolios drive market growth, emphasizing speed, reliability, and integration into healthcare systems.
Sales Revenue Highlights:
- Abbott: Approx. $43 billion (2022)
- Roche: Approx. $70 billion (2022)
- Thermo Fisher: Approx. $40 billion (2022)

Request Sample Report


Market Segmentation
By Application
Hospitals
◍ Clinics
◍ Home
◍ Assisted Living Healthcare Facilities
◍ Laboratories
By
Product
◍ HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus
associated infections
Respiratory syncytial virus (RSV) POC
◍ Others Request Sample Report
HPV POC
Influenza/Flu POC
Other Infectious Disease POC


Market Growth

Request Sample Report
$ X Billion USD












